Infant Bacterial Therapeutics
Maria Ekdahl has a diverse work experience primarily in financial roles. Maria served as a Chief Financial Officer at Infant Bacterial Therapeutics AB. Previously, they held various positions at the Swedish Film Institute, Coop Sverige, Karolinska Universitetssjukhuset, Telenor Sverige AB, Bredbandsbolaget, Hi3G Access AB, and Coca-Cola Sverige AB, where they gained extensive experience in financial management, business control, and project leadership.
Maria Ekdahl completed their Magister degree in Business Economics at Växjö University from 1994 to 1998.
This person is not in any teams
This person is not in any offices
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.